Tyra Biosciences reported net income of -$46.24M for the quarter ended Jun 2026. This income statement covers 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 9.16M | 13.78M | 41.70M | 41.90M | 42.14M | 42.35M | 42.54M | 42.82M | 42.93M | 43.02M | 52.47M | 52.74M | 52.87M | 50.75M | 53.09M | 53.23M | 53.32M | 53.71M | 59.47M | 59.66M | ||||
| Operating items | ||||||||||||||||||||||||
| Research & DevelopmentR&D | 5.48M | 7.25M | 9.64M | 12.05M | 10.91M | 10.40M | 10.41M | 12.16M | 19.27M | 20.68M | 17.20M | 18.00M | 22.70M | 22.18M | 24.96M | 24.31M | 25.47M | 28.19M | 33.47M | 39.20M | ||||
| Selling, General & AdministrativeSG&A | 1.15M | 2.68M | 5.19M | 3.38M | 2.73M | 4.62M | 3.93M | 3.85M | 4.69M | 4.96M | 5.12M | 5.54M | 5.91M | 7.56M | 6.89M | 7.14M | 7.47M | 8.33M | 8.53M | 9.81M | ||||
| Operating ExpensesOpex | 6.64M | 9.93M | 14.83M | 15.43M | 13.64M | 15.02M | 14.33M | 16.01M | 23.96M | 25.63M | 22.32M | 23.53M | 28.60M | 29.74M | 31.85M | 31.45M | 32.94M | 36.52M | 42.00M | 49.00M | ||||
| Operating IncomeOp. Inc | -6.64M | -9.93M | -14.83M | -15.43M | -13.64M | -15.02M | -14.33M | -16.01M | -23.96M | -25.63M | -22.32M | -23.53M | -28.60M | -29.74M | -31.85M | -31.45M | -32.94M | -36.52M | -42.00M | -49.00M | ||||
| EBIT | -6.64M | -9.93M | -14.83M | -15.43M | -13.64M | -15.02M | -14.33M | -16.01M | -23.96M | -25.63M | -22.32M | -23.53M | -28.60M | -29.74M | -31.85M | -31.45M | -32.94M | -36.52M | -42.00M | -49.00M | ||||
| Non-operating items | ||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.01M | 0.00M | 0.01M | 0.01M | 0.01M | 0.03M | 0.00M | 0.02M | ||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.00M | 0.01M | 0.02M | 0.35M | 1.13M | 2.16M | 2.45M | 2.74M | 2.81M | 2.80M | 4.13M | 4.83M | 4.59M | 4.17M | 3.70M | 3.35M | 3.08M | 2.68M | 2.69M | 3.44M | ||||
| Other Non Operating IncomeOther Non Op Inc. | 0.01M | -0.01M | ||||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | -0.01M | 0.00M | 0.01M | 0.33M | 1.14M | 2.12M | 2.45M | 2.74M | 2.81M | 2.80M | 4.13M | 4.83M | 4.59M | 4.17M | 3.70M | 3.35M | 3.08M | 2.68M | 2.69M | 3.44M | ||||
| Net income details | ||||||||||||||||||||||||
| EBT | -6.64M | -9.93M | -14.83M | -15.10M | -12.52M | -12.89M | -11.88M | -13.29M | -21.15M | -22.83M | -18.19M | -18.70M | -24.02M | -25.57M | -28.15M | -28.10M | -29.87M | -33.83M | -39.30M | -45.56M | ||||
| Profit After TaxPAT | -6.64M | -9.93M | -14.83M | -15.10M | -12.51M | -12.89M | -11.88M | -13.27M | -21.15M | -22.83M | -18.19M | -18.70M | -24.02M | -25.57M | -28.15M | -28.35M | -29.87M | -33.88M | -39.30M | -46.24M | ||||
| Income from Continuing OperationsIncome (Continuing) | -6.64M | -9.93M | -14.83M | -15.10M | -12.52M | -12.89M | -11.88M | -13.29M | -21.15M | -22.83M | -18.19M | -18.70M | -24.02M | -25.57M | -28.15M | -28.10M | -29.87M | -33.83M | -39.30M | -45.56M | ||||
| Consolidated Net IncomeConsol Net Inc. | -6.64M | -9.93M | -14.83M | -15.10M | -12.52M | -12.89M | -11.88M | -13.29M | -21.15M | -22.83M | -18.19M | -18.70M | -24.02M | -25.57M | -28.15M | -28.10M | -29.87M | -33.83M | -39.30M | -45.56M | ||||
| Income towards Parent CompanyParent Net Inc | -6.64M | -9.93M | -14.83M | -15.10M | -12.52M | -12.89M | -11.88M | -13.29M | -21.15M | -22.83M | -18.19M | -18.70M | -24.02M | -25.57M | -28.15M | -28.10M | -29.87M | -33.83M | -39.30M | -45.56M | ||||
| Net Income towards Common StockholdersNet Income | -6.64M | -9.93M | -14.83M | -15.10M | -12.52M | -12.89M | -11.88M | -13.29M | -21.15M | -22.83M | -18.19M | -18.70M | -24.02M | -25.57M | -28.15M | -28.10M | -29.87M | -33.83M | -39.30M | -45.56M | ||||
| Additional items | ||||||||||||||||||||||||
| EPS (Basic) | -0.72 | -0.72 | -0.36 | -0.36 | -0.30 | -0.31 | -0.28 | -0.31 | -0.49 | -0.53 | -0.35 | -0.32 | -0.41 | -0.45 | -0.47 | -0.47 | -0.50 | -0.57 | -0.64 | -0.69 | ||||
| EPS (Diluted) | -0.72 | -0.72 | -0.36 | -0.36 | -0.30 | -0.31 | -0.28 | -0.31 | -0.49 | -0.53 | -0.35 | -0.32 | -0.41 | -0.45 | -0.47 | -0.47 | -0.50 | -0.57 | -0.64 | -0.69 | ||||
| Shares Outstanding | 9.16M | 13.78M | 41.55M | 41.78M | 42.00M | 41.88M | 42.39M | 42.59M | 42.87M | 42.70M | 52.23M | 58.67M | 58.87M | 57.22M | 59.34M | 59.55M | 59.67M | 59.60M | 61.75M | 65.99M | ||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 9.16M | 13.78M | 41.55M | 41.78M | 42.00M | 41.88M | 42.39M | 42.59M | 42.87M | 42.70M | 52.23M | 58.67M | 58.87M | 57.22M | 59.34M | 59.55M | 59.67M | 59.60M | 61.75M | 65.99M | ||||
| EBITDA | -6.64M | -9.93M | -14.83M | -15.43M | -13.64M | -15.02M | -14.33M | -16.01M | -23.96M | -25.63M | -22.32M | -23.53M | -28.60M | -29.74M | -31.85M | -31.45M | -32.94M | -36.52M | -42.00M | -49.00M | ||||
| Interest ExpensesInt Expense | 0.01M | 0.00M | 0.01M | 0.01M | 0.01M | 0.03M | 0.00M | 0.02M |